These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, Milburn MV, Rosenfeld MG, Glass CK. Nature; 1998 Sep 10; 395(6698):199-202. PubMed ID: 9744281 [Abstract] [Full Text] [Related]
3. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. Johnson BA, Wilson EM, Li Y, Moller DE, Smith RG, Zhou G. J Mol Biol; 2000 Apr 28; 298(2):187-94. PubMed ID: 10764590 [Abstract] [Full Text] [Related]
4. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators. Jin KS, Park JK, Yoon J, Rho Y, Kim JH, Kim EE, Ree M. J Phys Chem B; 2008 Aug 14; 112(32):9603-12. PubMed ID: 18646811 [Abstract] [Full Text] [Related]
5. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, Stimmel JB. Biochemistry; 2003 Aug 12; 42(31):9278-87. PubMed ID: 12899614 [Abstract] [Full Text] [Related]
6. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB. Nature; 2002 Feb 14; 415(6873):813-7. PubMed ID: 11845213 [Abstract] [Full Text] [Related]
7. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, Ortlund EA. J Mol Biol; 2005 Dec 16; 354(5):1091-102. PubMed ID: 16289203 [Abstract] [Full Text] [Related]
8. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Nichols JS, Parks DJ, Consler TG, Blanchard SG. Anal Biochem; 1998 Mar 15; 257(2):112-9. PubMed ID: 9514791 [Abstract] [Full Text] [Related]
9. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus. Shiraki T, Kodama TS, Jingami H, Kamiya N. Proteins; 2005 Feb 01; 58(2):418-25. PubMed ID: 15558556 [Abstract] [Full Text] [Related]
10. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis. Kammerer S, Germain P, Flaig R, Peluso-Iltis C, Mitschler A, Rochel N, Gronemeyer H, Moras D. Acta Crystallogr D Biol Crystallogr; 2004 Nov 01; 60(Pt 11):2048-50. PubMed ID: 15502323 [Abstract] [Full Text] [Related]
11. SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domain. Babb R, Bowen BR. Biochem J; 2003 Mar 01; 370(Pt 2):719-27. PubMed ID: 12444922 [Abstract] [Full Text] [Related]
12. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Vanhooke JL, Benning MM, Bauer CB, Pike JW, DeLuca HF. Biochemistry; 2004 Apr 13; 43(14):4101-10. PubMed ID: 15065852 [Abstract] [Full Text] [Related]
13. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M, Fournier B. J Biol Chem; 2004 Nov 19; 279(47):49330-7. PubMed ID: 15337744 [Abstract] [Full Text] [Related]
14. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. J Mol Biol; 2001 Mar 23; 307(2):557-76. PubMed ID: 11254382 [Abstract] [Full Text] [Related]
15. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Sheu SH, Kaya T, Waxman DJ, Vajda S. Biochemistry; 2005 Feb 01; 44(4):1193-209. PubMed ID: 15667213 [Abstract] [Full Text] [Related]
16. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Li Y, Suino K, Daugherty J, Xu HE. Mol Cell; 2005 Aug 05; 19(3):367-80. PubMed ID: 16061183 [Abstract] [Full Text] [Related]
17. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma. Gani OA, Sylte I. Chem Biol Drug Des; 2008 Jul 05; 72(1):50-7. PubMed ID: 18554251 [Abstract] [Full Text] [Related]
19. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. Watkins RE, Davis-Searles PR, Lambert MH, Redinbo MR. J Mol Biol; 2003 Aug 22; 331(4):815-28. PubMed ID: 12909012 [Abstract] [Full Text] [Related]
20. A simple ELISA for screening ligands of peroxisome proliferator-activated receptor-gamma. Cho MC, Lee HS, Kim JH, Choe YK, Hong JT, Paik SG, Yoon DY. J Biochem Mol Biol; 2003 Mar 31; 36(2):207-13. PubMed ID: 12689521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]